Anaphylaxis After Two Epinephrine Doses: When to Infuse

Anaphylaxis After Two Epinephrine Doses: When to Infuse

By Chester "Chet" Shermer, MD, FACEP  •  2026-11-19  •  12 min read  •  Pharmacology

At 1430 a 34-year-old roofer stung on the neck twenty minutes ago is sitting on the tailgate of his truck, hoarse, wheezing, and covered in hives. His coworker already gave him the patient's own 0.3 mg autoinjector. You give 0.5 mg of 1 mg/mL epinephrine IM into the anterolateral thigh. Five minutes later his blood pressure is 82/50 and his voice is worse. You get him off his feet onto the stretcher while your partner gets a line. That makes two doses of epinephrine and no response.

Bottom line: count every IM or intranasal dose, whoever gave it, repeat IM or intranasal epinephrine every 5 minutes while the patient is in shock or respiratory failure, and treat two doses without a response as the trigger to prepare an epinephrine infusion or to call for a team that can run one.

The Second Dose Comes at Five Minutes

Current pathways give IM or intranasal epinephrine at once and repeat it every 5 to 15 minutes while anaphylaxis persists [1]. Patients in respiratory failure or shock should get a dose every 5 minutes [1].

About 10% of reactions respond poorly to a single dose, and only about 2% fail to respond to two [1,2].

The count starts before you arrive. The 2026 clinical care pathway, from a 30-member international panel with prehospital expertise, counts every IM or intranasal dose, whoever gave it [1]. The coworker's autoinjector is dose one. An intranasal spray the patient used at home is dose one. Nebulized epinephrine for stridor does not count toward the total [1]. Ask and record the time.

Intranasal epinephrine (neffy, 2 mg) was approved on pharmacokinetic data, and no trial has compared it with IM epinephrine in patients with anaphylaxis [1]. In 59 healthy volunteers its mean peak level fell between a 0.3 mg autoinjector and a 0.3 mg manual IM injection [8]. The pathway treats the two routes as equal and lets you switch between them [1].

Most autoinjectors deliver 0.3 mg, while the 2021 Resuscitation Council UK (RCUK) review gives 0.5 mg as the dose for teenagers and adults, and coroners' inquests have found that autoinjectors can underdose in a way that may contribute to deaths [2]. The review advises giving further doses by needle and syringe so the patient gets the full dose [2]. For children, international guidelines use 0.01 mg/kg, maximum 0.5 mg [2].

In an emergency department cohort of 582 patients, 8% needed more than one dose; the predictors were prior anaphylaxis, flushing or diaphoresis, and dyspnea [3]. Beta-blocker use was not significantly associated with needing more than one dose in 789 ED visits (OR 1.26, 95% CI 0.58 to 2.75), though the study was small [4]. Both studies come from one academic ED.

No Response After Two, Prepare to Infuse

A 2020 expert panel defined refractory anaphylaxis as anaphylaxis that persists despite appropriate epinephrine and symptom-directed care and that needs three or more doses or an IV infusion [1]. It is uncommon: 0.4% of 11,596 patients in the European Anaphylaxis Registry and 2.1% of 5,641 children in a North American ED cohort [1]. It is deadly: in the European registry, mortality was 26.2% with refractory anaphylaxis against 0.4% with severe reactions that were not refractory [1].

The 2026 pathway puts the rule in one phrase: "If there is no response after two, prepare to infuse" [1]. Give a third dose if 5 minutes have passed and the infusion is not ready. Start the infusion after the third dose, or sooner for shock or respiratory failure [1].

Meanwhile, do the basics well:

For crews without an epinephrine infusion, the pathway is direct: keep giving IM or intranasal epinephrine every 5 minutes, request a higher-level intercept (ALS or critical care), and get guidance from medical control while you wait [1]. The panel discourages infusions by providers without infusion training because of dosing errors, ischemia and arrhythmias [1]. Your protocol and medical director set which of these your crew does.

Running the Infusion in Transport

Bolus epinephrine can impair ventricular function and venous return in animal and human data, and a continuous infusion gives steady drug levels that you can titrate [1]. The pathway keeps IV bolus dosing, with its dosing errors and complications, for impending cardiopulmonary arrest and for when an infusion cannot start promptly; untrained providers continue IM or intranasal dosing [1].

One preparation in the pathway is 1 mg of 1 mg/mL epinephrine added to 100 mL of 0.9% saline, which gives 10 mcg/mL [1]. The panel asks for a formal protocol that includes infusion dosing, and for the team to always verify the concentration and the starting rate [1]. Take the rate from your protocol or from medical control. Concentration mix-ups are the error in our post on dangerous prehospital drug errors.

Titrate to blood pressure, heart rate, rhythm and the examination. Reduce or stop the infusion for excessive hypertension, signs of cardiac ischemia, or a tachyarrhythmia, and wean it slowly once the cardiopulmonary findings resolve [1].

Biphasic Reactions and the Patient Who Wants to Stay Home

A biphasic reaction is a return of symptoms without new exposure. The RCUK review reports a pooled biphasic rate of 4.6% [2]. In a meta-analysis of 27 studies, the median onset of the second phase was 11 hours, with a range of 0.2 to 72 hours [5]. Risk was higher when the first presentation included hypotension or the trigger was unknown, and lower when food was the trigger [5].

Treatment history adds to the risk. In data summarized by the RCUK review, a severe first presentation (OR 2.11) and more than one dose of epinephrine (OR 4.82) were associated with biphasic anaphylaxis, and so was epinephrine given more than 30 minutes after symptoms began (OR 3.39 in a prospective cohort of 430 reactions) [2]. Antihistamines do not prevent biphasic reactions, and there is no evidence that corticosteroids do [2].

The 2023 US practice parameter says that, after prompt epinephrine in the community, immediate EMS activation may not be needed if the response is prompt, complete and durable [6]. That is guidance for patients and caregivers at home. The patient who needed you is different: hypotension, a severe first reaction, or a second dose puts him in the higher-risk groups above.

Children have their own data, and they measure repeat dosing rather than biphasic reactions. In a 31-site ED cohort of 5,641 children aged 6 months to 17 years, the outcome was time from first to last epinephrine dose: 4.7% got repeat epinephrine more than 2 hours after the first dose and 1.9% more than 4 hours after it [7]. The authors concluded that 2 hours of observation is probably safe for most children, and 4 hours might be enough for well-appearing children with cardiovascular involvement [7].

For the adult with capacity who declines after one dose and full resolution, use our high-risk refusal checklist and the biphasic facts above.

Key Takeaways

FAQ

How often can you repeat epinephrine for anaphylaxis?

Every 5 to 15 minutes while symptoms persist, and every 5 minutes for a patient in shock or respiratory failure [1]. After two doses without a response, prepare an infusion and keep dosing every 5 minutes until it runs [1].

When do you start an epinephrine infusion for anaphylaxis?

Prepare it after two doses with no response, and start it after the third dose or sooner for shock or respiratory failure [1]. Only clinicians trained in epinephrine infusions should run one. A crew without that training keeps giving IM or intranasal doses every 5 minutes and calls for an intercept [1].

How long should a patient be observed after anaphylaxis?

The optimal duration is not known, and the UK guidance uses a risk-based approach rather than one fixed time [2]. Biphasic reactions occur in about 5% of patients [2], and in one meta-analysis half began more than 11 hours after the first symptoms [5]. Patients who needed more than one dose or had a severe first reaction are at higher risk [2].

Dr. Chet's Take

I have practiced emergency medicine for more than 25 years, I work at a Level I academic trauma center, and I serve as medical director for a HEMS and critical care ground transport service. This article gets the order of operations right: epinephrine early, epinephrine again at five minutes when the patient is sick, and a plan for the infusion before you need it. The core argument holds. The risk I worry about most is not the first dose. It is the gap after it, when the patient looks a little better, attention turns to the antihistamine or the IV, and nobody is watching the clock for the next dose. A partial response is not a resolved reaction. A voice that is still hoarse or a pressure that is drifting down is a reason to dose again now.

That being said, the escalation rule only works if the crew can count. "Two doses" means IM or intranasal doses, and it sounds simple until the first one was the patient's own pen in the parking lot, the second came from a first responder, and neither time made it into the chart. The honest answer is that I cannot tell you how often a refractory reaction is recognized late because nobody knew the count. That is the problem. If the chart cannot answer it, the next team cannot either. The fix is procedural. One person owns the epinephrine clock out loud, calls each dose and its time to the crew, and repeats the count at handoff. A receiving team that hears "three doses, last one at 1452, pressure still soft" starts the infusion. A team that hears "he got some epi" starts over.

If you are the medical director, decide now which of your units run an epinephrine infusion, which concentration they carry, and who they call when they cannot, and put it in writing. Then pull every anaphylaxis chart with two or more doses and check whether each dose has a time and a route. If you are running this call without an infusion, keep dosing every five minutes, ask for the intercept early, and do not let a long transport talk you into waiting. If you are flying, have the infusion mixed and labeled before you lift with a patient who has already had two doses. Refractory anaphylaxis is rare, and that is the reason the plan has to exist before the patient does.

— Chester Shermer, MD, FACEP | Emergency Medicine, 25+ Years Clinical Experience | State Surgeon

Continue Your Training

If you're an EMT, paramedic, flight medic, or CCTP (or any clinician treating patients daily) trying to understand how AI will actually impact your clinical practice — not just the hype — I put together a free practical guide. You can download the AI in EM Survival Guide here.

Browse All Courses at Global MedOps Command

Relevant Reading on Global MedOps Command:

How to Avoid Becoming an AI Casualty — Dr. Shermer's guide to navigating AI tools in clinical and operational settings without compromising judgment or patient outcomes.

Emergency Department Efficiency Playbook — Practical systems for throughput, triage optimization, and operational efficiency.

Read more from Dr. Shermer on Medium

Connect with Dr. Shermer: LinkedIn — Chester "Chet" Shermer, MD, FACEP.

References

  1. Dribin TE, Sobolewski B, Campbell RL, et al. Anaphylaxis clinical care pathway: incorporating intranasal epinephrine (adrenaline). J Allergy Clin Immunol Pract. 2026;14(10):2254-2261. PubMed 42447993
  2. Dodd A, Hughes A, Sargant N, et al. Evidence update for the treatment of anaphylaxis. Resuscitation. 2021;163:86-96. PubMed 33895231
  3. Campbell RL, Bashore CJ, Lee S, et al. Predictors of repeat epinephrine administration for emergency department patients with anaphylaxis. J Allergy Clin Immunol Pract. 2015;3(4):576-584. PubMed 26032476
  4. White JL, Greger KC, Lee S, et al. Patients taking β-blockers do not require increased doses of epinephrine for anaphylaxis. J Allergy Clin Immunol Pract. 2018;6(5):1553-1558.e1. PubMed 29449164
  5. Lee S, Bellolio MF, Hess EP, et al. Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2015;3(3):408-416. PubMed 25680923
  6. Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124-176. PubMed 38108678
  7. Dribin TE, Sampson HA, Zhang Y, et al. Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study. Lancet Child Adolesc Health. 2025;9(7):484-496. PubMed 40506197
  8. Casale TB, Ellis AK, Nowak-Wegrzyn A, et al. Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection. J Allergy Clin Immunol. 2023;152(6):1587-1596. PubMed 37604314

Related simulation training: EMS-MedSim · EM-Sim · Books by Dr. Shermer

Related articles